Severe Iron Deficiency Anemia Requiring Urgent Investigation and Treatment
This patient has severe iron deficiency anemia with a critically low transferrin saturation of 5% and serum iron of 18 µg/dL, requiring immediate iron replacement therapy and urgent gastrointestinal evaluation to identify the source of iron loss.
Diagnosis
The laboratory findings definitively establish iron deficiency anemia:
- Transferrin saturation 5% (critically low; normal >20%) 1
- Serum iron 18 µg/dL (severely depleted)
- TIBC 377 µg/dL (elevated, indicating iron deficiency)
- Elevated RDW-CV 20% and RDW-SD 52 fL (marked anisocytosis characteristic of iron deficiency) 2, 3
- Thrombocytosis (platelets 434) - reactive thrombocytosis commonly occurs with iron deficiency, correlating inversely with serum iron and transferrin saturation 4, 5
- Normal B12 1200 pg/mL excludes B12 deficiency
The severely elevated RDW (>17.1%) strongly indicates iron deficiency anemia rather than thalassemia trait 3. The combination of RDW-CV >15% with transferrin saturation <16% has high specificity for iron deficiency 6.
Immediate Management Algorithm
1. Initiate Iron Replacement Immediately
Given the severe iron deficiency (transferrin saturation 5%), start treatment now:
- First-line: Oral iron supplementation - elemental iron 100-200 mg daily 7, 1
- Monitor response at 2 weeks: Hemoglobin should rise ≥10 g/L within 2 weeks, confirming iron deficiency even if other studies were equivocal 1
- Switch to IV iron if:
- Poor tolerance to oral iron (nausea, constipation, abdominal pain)
- Inadequate response after 4-6 weeks
- Severe anemia with symptoms
- Ongoing blood loss 7
2. Urgent Gastrointestinal Investigation
All adults with new iron deficiency anemia without obvious explanation require urgent GI evaluation 1. This is critical because:
- Iron deficiency anemia can indicate GI malignancy 1
- The severely low transferrin saturation indicates significant ongoing iron loss or malabsorption
Investigation pathway:
- Bidirectional endoscopy (gastroscopy + colonoscopy) as first-line investigation 1
- Screen for celiac disease - serologic testing or small bowel biopsy at gastroscopy (found in 3-5% of IDA cases) 1
- Urinalysis to exclude urinary blood loss 1
- If initial endoscopy negative and anemia persists/recurs: capsule endoscopy for small bowel evaluation 1
3. Assess for Contributing Factors
Obtain detailed history focusing on:
- Dietary iron intake (vegetarian diet, poor nutrition)
- Menstrual history if premenopausal woman
- Medications: NSAIDs, aspirin, anticoagulants causing occult GI bleeding 1
- GI symptoms: dyspepsia, change in bowel habits, visible blood loss
- Helicobacter pylori infection (can impair iron absorption) 7
Critical Pitfalls to Avoid
Do not delay investigation waiting for iron studies to "normalize" - the severely low transferrin saturation and elevated RDW already confirm iron deficiency 1
Do not assume dietary deficiency alone - this degree of iron deficiency in adults typically indicates pathologic blood loss requiring investigation 1
Do not miss celiac disease - routinely screen all IDA patients as it's found in 3-5% and requires specific management (gluten-free diet) 1
Monitor platelet count - the reactive thrombocytosis (434) should normalize with iron repletion; persistent elevation warrants hematology evaluation 4, 5
If ferritin were available and <45 µg/L, this would provide additional confirmation, though the transferrin saturation of 5% is already diagnostic 7, 1
Expected Response to Treatment
- Hemoglobin rise ≥10 g/L within 2 weeks confirms appropriate response 1
- Platelet count should decrease toward normal as iron stores replete 4
- RDW should gradually normalize over months as new normocytic red cells replace the anisocytic population 2, 3
- Continue iron supplementation for 3-6 months after hemoglobin normalizes to replete iron stores 7
If no response to oral iron within 2-4 weeks or ongoing symptoms, switch to intravenous iron formulations 7.